pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›recall
recall
save

GenoGenix LLC recall (Cls II)

October 15, 2025updated 5mo ago
community read0 votes

Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Synergy Wellness, 20 mg, 10mL vial lyophilized. — Reason: Lack of Assurance of Sterility — Status: Ongoing

view source ↗
Data sources
fda recalls
last refreshed 57m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • recallGenoGenix LLC recall (Cls II)Oct 15, 2025
  • approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalOct 14, 2025
  • approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalOct 14, 2025
  • approvalWEGOVY (SEMAGLUTIDE) — FDA approvalOct 14, 2025
  • approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalOct 17, 2025
  • approvalOZEMPIC (SEMAGLUTIDE) — FDA approvalOct 17, 2025

🐶 often sniffed alongside

top 7
  • companyNovo Nordisk Inc2 co-mentions · 2 sources
  • tagHepatology2 co-mentions · 1 sources
  • tagObesity2 co-mentions · 1 sources
  • tagEndocrinology & Metabolism1 co-mentions · 1 sources
  • drugObesity1 co-mentions · 1 sources
  • drugzalfermin1 co-mentions · 1 sources
  • drugcagrilintide hydrochloride1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?